Fig. 2From: Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s diseaseADAS-cog scores in subjects treated with simvastatin or placebo. a ADAS-cog scores over time in different genotype subgroups. b Change in ADAS-cog scores from baseline in different genotype subgroups. ADAS-cog Alzheimer’s Disease Assessment Scale—cognitive subscale, ApoE apolipoprotein EBack to article page